Hematology-oncology provider perspectives regarding lymphoma treatment and cardioprotective strategies in patients with lymphoma at high risk for heart failure

By sjmartinez • April 8, 2025

Anderson E, Choi Y, Buchsbaum RJ, Klein A, Ky B, Landsburg D, Durani U, Ruddy KJ, Yu AF, Leong D, Asnani A, Neilan TG, Ganatra S, Bloom M, Barac A, Yang EH, Deswal A, Cheng RK, Weiss M, Evens AM, Kahl B, Friedberg JW, Parsons SK, Upshaw JN. Hematology-oncology provider perspectives regarding lymphoma treatment and cardioprotective strategies in patients with lymphoma at high risk for heart failure. Leuk Lymphoma. 2025 Apr 8:1-10. doi: 10.1080/10428194.2025.2484367. Epub ahead of print. PMID: 40195874.

Tags: anthracycline, Cancer, Cancer survivorship, Cardiology/Epi, cardiomyopathy, cardioprotection, heart failure, Publications

Breaking the Chain of Survival: What Progetto Vita Tells Us, and What It Doesn’t

Talishinsky A, Ajijola OA, Salhi RA. Breaking the Chain of Survival: What Progetto Vita Tells Us, and What It Doesn't. J Am Heart Assoc. 2025[...]

Early Structural Deterioration of a Self-Expanding Transcatheter Aortic Valve Prosthesis Presenting With Severe Aortic Insufficiency: A Case Report

Dave PR, Hacobian M. Early Structural Deterioration of a Self-Expanding Transcatheter Aortic Valve Prosthesis Presenting With Severe Aortic Insufficiency: A Case Report. Cureus. 2025 Sep[...]

Comorbidity patterns and mortality in HFpEF: A retrospective longitudinal cohort study

Yousufuddin M, Ma Z, Barkoudah E, Tahir MW, Yazdanyar A, Chikkanna R, Benkhadra K, Bhagra S, Fonarow GC, Yamani MH. Comorbidity patterns and mortality in[...]